Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption

Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-lau...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2009-07, Vol.385 (2), p.154-159
Hauptverfasser: Yi, Jae-Sung, Choo, Hyo-Jung, Cho, Bong-Rae, Kim, Hwan-Myung, Kim, Yong-Nyun, Ham, Young-Mi, Ko, Young-Gyu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 159
container_issue 2
container_start_page 154
container_title Biochemical and biophysical research communications
container_volume 385
creator Yi, Jae-Sung
Choo, Hyo-Jung
Cho, Bong-Rae
Kim, Hwan-Myung
Kim, Yong-Nyun
Ham, Young-Mi
Ko, Young-Gyu
description Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.
doi_str_mv 10.1016/j.bbrc.2009.05.028
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_22199742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X09009358</els_id><sourcerecordid>67339750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVoaTab_oEciqGQm52R5A8JcikhXxAI9ANyE7I0brTsyo4kL_TfR2YXestlhmHeeRgeQi4oVBRoe7Wp-j6YigHICpoKmDghKwoSSkah_kRWANCWTNKXU3IW4waA0rqVX8gplXXdCClW5Ne98xH9GJ3F4ucrK5y3s8FYbN1f7W2ZR5wwF5-KOx0LbZLb6-RGX-ydzqnJ2SLoIRXWxTBPy-acfB70NuLXY1-TP3e3v28eyqfn-8ebH0-l4YKlUtMea-hE01KLojWMcgEDaziHwQiEvmZc5KExHKjg1nTYd0xDKzj0EoCvyfcDd4zJqWhcQvNqRu_RJMUYlbLLiDW5PKSmML7NGJPauWhwu9UexzmqtuNcds2CY4egCWOMAQc1BbfT4Z-ioBbhaqMW4WoRrqBRWXg--nakz_0O7f-To-EcuD4EMJvYOwzLo-gNWheWP-3oPuK_Aw4tkDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67339750</pqid></control><display><type>article</type><title>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yi, Jae-Sung ; Choo, Hyo-Jung ; Cho, Bong-Rae ; Kim, Hwan-Myung ; Kim, Yong-Nyun ; Ham, Young-Mi ; Ko, Young-Gyu</creator><creatorcontrib>Yi, Jae-Sung ; Choo, Hyo-Jung ; Cho, Bong-Rae ; Kim, Hwan-Myung ; Kim, Yong-Nyun ; Ham, Young-Mi ; Ko, Young-Gyu</creatorcontrib><description>Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2009.05.028</identifier><identifier>PMID: 19445898</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Antineoplastic Agents - pharmacology ; APOPTOSIS ; Caveolin 1 - metabolism ; CELL PROLIFERATION ; CHOLESTEROL ; Cholesterol - metabolism ; Fas activation ; fas Receptor - metabolism ; Ginsenoside Rh2 ; Ginsenosides - pharmacology ; HELA CELLS ; Humans ; LIGANDS ; Lipid rafts ; LIPIDS ; Membrane Microdomains - drug effects ; Membrane Microdomains - metabolism ; PHOTONS ; SACCHAROSE ; ULTRACENTRIFUGATION</subject><ispartof>Biochemical and biophysical research communications, 2009-07, Vol.385 (2), p.154-159</ispartof><rights>2009 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</citedby><cites>FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2009.05.028$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19445898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22199742$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Yi, Jae-Sung</creatorcontrib><creatorcontrib>Choo, Hyo-Jung</creatorcontrib><creatorcontrib>Cho, Bong-Rae</creatorcontrib><creatorcontrib>Kim, Hwan-Myung</creatorcontrib><creatorcontrib>Kim, Yong-Nyun</creatorcontrib><creatorcontrib>Ham, Young-Mi</creatorcontrib><creatorcontrib>Ko, Young-Gyu</creatorcontrib><title>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>APOPTOSIS</subject><subject>Caveolin 1 - metabolism</subject><subject>CELL PROLIFERATION</subject><subject>CHOLESTEROL</subject><subject>Cholesterol - metabolism</subject><subject>Fas activation</subject><subject>fas Receptor - metabolism</subject><subject>Ginsenoside Rh2</subject><subject>Ginsenosides - pharmacology</subject><subject>HELA CELLS</subject><subject>Humans</subject><subject>LIGANDS</subject><subject>Lipid rafts</subject><subject>LIPIDS</subject><subject>Membrane Microdomains - drug effects</subject><subject>Membrane Microdomains - metabolism</subject><subject>PHOTONS</subject><subject>SACCHAROSE</subject><subject>ULTRACENTRIFUGATION</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVoaTab_oEciqGQm52R5A8JcikhXxAI9ANyE7I0brTsyo4kL_TfR2YXestlhmHeeRgeQi4oVBRoe7Wp-j6YigHICpoKmDghKwoSSkah_kRWANCWTNKXU3IW4waA0rqVX8gplXXdCClW5Ne98xH9GJ3F4ucrK5y3s8FYbN1f7W2ZR5wwF5-KOx0LbZLb6-RGX-ydzqnJ2SLoIRXWxTBPy-acfB70NuLXY1-TP3e3v28eyqfn-8ebH0-l4YKlUtMea-hE01KLojWMcgEDaziHwQiEvmZc5KExHKjg1nTYd0xDKzj0EoCvyfcDd4zJqWhcQvNqRu_RJMUYlbLLiDW5PKSmML7NGJPauWhwu9UexzmqtuNcds2CY4egCWOMAQc1BbfT4Z-ioBbhaqMW4WoRrqBRWXg--nakz_0O7f-To-EcuD4EMJvYOwzLo-gNWheWP-3oPuK_Aw4tkDg</recordid><startdate>20090724</startdate><enddate>20090724</enddate><creator>Yi, Jae-Sung</creator><creator>Choo, Hyo-Jung</creator><creator>Cho, Bong-Rae</creator><creator>Kim, Hwan-Myung</creator><creator>Kim, Yong-Nyun</creator><creator>Ham, Young-Mi</creator><creator>Ko, Young-Gyu</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20090724</creationdate><title>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</title><author>Yi, Jae-Sung ; Choo, Hyo-Jung ; Cho, Bong-Rae ; Kim, Hwan-Myung ; Kim, Yong-Nyun ; Ham, Young-Mi ; Ko, Young-Gyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>APOPTOSIS</topic><topic>Caveolin 1 - metabolism</topic><topic>CELL PROLIFERATION</topic><topic>CHOLESTEROL</topic><topic>Cholesterol - metabolism</topic><topic>Fas activation</topic><topic>fas Receptor - metabolism</topic><topic>Ginsenoside Rh2</topic><topic>Ginsenosides - pharmacology</topic><topic>HELA CELLS</topic><topic>Humans</topic><topic>LIGANDS</topic><topic>Lipid rafts</topic><topic>LIPIDS</topic><topic>Membrane Microdomains - drug effects</topic><topic>Membrane Microdomains - metabolism</topic><topic>PHOTONS</topic><topic>SACCHAROSE</topic><topic>ULTRACENTRIFUGATION</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yi, Jae-Sung</creatorcontrib><creatorcontrib>Choo, Hyo-Jung</creatorcontrib><creatorcontrib>Cho, Bong-Rae</creatorcontrib><creatorcontrib>Kim, Hwan-Myung</creatorcontrib><creatorcontrib>Kim, Yong-Nyun</creatorcontrib><creatorcontrib>Ham, Young-Mi</creatorcontrib><creatorcontrib>Ko, Young-Gyu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yi, Jae-Sung</au><au>Choo, Hyo-Jung</au><au>Cho, Bong-Rae</au><au>Kim, Hwan-Myung</au><au>Kim, Yong-Nyun</au><au>Ham, Young-Mi</au><au>Ko, Young-Gyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2009-07-24</date><risdate>2009</risdate><volume>385</volume><issue>2</issue><spage>154</spage><epage>159</epage><pages>154-159</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19445898</pmid><doi>10.1016/j.bbrc.2009.05.028</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2009-07, Vol.385 (2), p.154-159
issn 0006-291X
1090-2104
language eng
recordid cdi_osti_scitechconnect_22199742
source MEDLINE; Elsevier ScienceDirect Journals
subjects 60 APPLIED LIFE SCIENCES
Antineoplastic Agents - pharmacology
APOPTOSIS
Caveolin 1 - metabolism
CELL PROLIFERATION
CHOLESTEROL
Cholesterol - metabolism
Fas activation
fas Receptor - metabolism
Ginsenoside Rh2
Ginsenosides - pharmacology
HELA CELLS
Humans
LIGANDS
Lipid rafts
LIPIDS
Membrane Microdomains - drug effects
Membrane Microdomains - metabolism
PHOTONS
SACCHAROSE
ULTRACENTRIFUGATION
title Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T09%3A56%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ginsenoside%20Rh2%20induces%20ligand-independent%20Fas%20activation%20via%20lipid%20raft%20disruption&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Yi,%20Jae-Sung&rft.date=2009-07-24&rft.volume=385&rft.issue=2&rft.spage=154&rft.epage=159&rft.pages=154-159&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2009.05.028&rft_dat=%3Cproquest_osti_%3E67339750%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67339750&rft_id=info:pmid/19445898&rft_els_id=S0006291X09009358&rfr_iscdi=true